1Q3A | C:107-263; C:107-263; C:107-263 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 10 |
1JIZ | B:9-164; B:9-164 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN MACROPHAGE ELASTASE MMP-12 |
1JK3 | A:108-263 | CRYSTAL STRUCTURE OF HUMAN MMP-12 (MACROPHAGE ELASTASE) AT TRUE ATOMIC RESOLUTION |
1OS2 | F:108-263; F:108-263; F:108-263; F:108-263; F:108-263; F:108-263 | TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12 |
1OS9 | F:108-263; F:108-263; F:108-263; F:108-263; F:108-263; F:108-263 | BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12 |
1RMZ | A:108-263 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR NNGH AT 1.3 A RESOLUTION |
1ROS | B:108-263; B:108-263 | CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[1,1-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID |
1UTT | A:108-263 | CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[1,1-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID |
1UTZ | B:108-263; B:108-263 | CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO (2R)-3-({[4-[(PYRI DIN-4-YL)PHENYL]-THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID |
1YCM | A:108-263 | SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 12 (MMP12) IN THE PRESENCE OF N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) |
2K2G | A:108-263 | SOLUTION STRUCTURE OF THE WILD-TYPE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 12 (MMP-12) IN COMPLEX WITH A TIGHT-BINDING INHIBITOR |
2KRJ | A:112-263 | HIGH-RESOLUTION SOLID-STATE NMR STRUCTURE OF A 17.6 KDA PROTEIN |
2OXU | A:108-263 | UNINHIBITED FORM OF HUMAN MMP-12 |
2OXZ | A:108-263 | HUMAN MMP-12 IN COMPLEX WITH TWO PEPTIDES PQG AND IAG |
2POJ | A:108-263 | NMR SOLUTION STRUCTURE OF THE INHIBITOR-FREE STATE OF MACROPHAGE METALLOELASTASE (MMP-12) |
2W0D | D:108-263; D:108-263; D:108-263; D:108-263 | DOES A FAST NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY- AND X-RAY CRYSTALLOGRAPHY HYBRID APPROACH PROVIDE RELIABLE STRUCTURAL INFORMATION OF LIGAND-PROTEIN COMPLEXES? A CASE STUDY OF METALLOPROTEINASES. |
2WO8 | D:108-263; D:108-263; D:108-263; D:108-263 | MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID |
2WO9 | D:108-263; D:108-263; D:108-263; D:108-263 | MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID |
2WOA | D:108-263; D:108-263; D:108-263; D:108-263 | MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID |
2Z2D | A:108-263 | SOLUTION STRUCTURE OF HUMAN MACROPHAGE ELASTASE (MMP-12) CATALYTIC DOMAIN COMPLEXED WITH A GAMMA-KETO BUTANOIC ACID INHIBITOR |
3LIK | A:108-263 | HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR |
3LIL | A:108-263 | HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR |
3LIR | A:108-263 | HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR |
3LJG | A:108-263 | HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR |
3LK8 | A:108-263 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR PARAMETHOXY-SULFONYL-GLYCINE HYDROXAMATE |
3LKA | A:108-263 | CATALYTIC DOMAIN OF HUMAN MMP-12 COMPLEXED WITH HYDROXAMIC ACID AND PARAMETHOXY-SULFONYL AMIDE |
3N2U | A:108-263 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(4-METHOXY-N(2-(3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YLOXY)ETHYL)PHENYLSULFONAMIDO) ACETAMIDE |
3N2V | A:108-263 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(N-HYDROXYETHYL)BIPHENYL-4-YLSULFONAMIDO)ACETAMIDE |
3NX7 | A:108-263 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(N-(2-HYDROXYETHYL)4-METHOXYPHENYLSULFONAMIDO)ACETAMIDE |
1XUC | B:112-267; B:112-267 | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR |
1XUD | B:112-267; B:112-267 | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR |
1XUR | B:112-267; B:112-267 | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR |
1YOU | B:112-267; B:112-267 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH A POTENT PYRIMIDINETRIONE INHIBITOR |
1ZTQ | D:87-242; D:87-242; D:87-242; D:87-242 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-033 |
2OW9 | B:91-246; B:91-246 | CRYSTAL STRUCTURE ANALYSIS OF THE MMP13 CATALYTIC DOMAIN IN COMPLEX WITH SPECIFIC INHIBITOR |
2OZR | H:91-246; H:91-246; H:91-246; H:91-246; H:91-246; H:91-246; H:91-246; H:91-246 | MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID |
2PJT | D:87-242; D:87-242; D:87-242; D:87-242 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-344 |
2YIG | B:112-267; B:112-267 | MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR |
3KEC | B:112-267; B:112-267 | CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A PHENYL-2H-TETRAZOLE COMPOUND |
3KEJ | B:112-266; B:112-266 | CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H-TETRAZOLE COMPOUND |
3KEK | B:112-267; B:112-267 | CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H-TETRAZOLE COMPOUND |
3KRY | D:112-267; D:112-267; D:112-267; D:112-267 | CRYSTAL STRUCTURE OF MMP-13 IN COMPLEX WITH SC-78080 |
3LJZ | D:112-267; D:112-267; D:112-267; D:112-267 | CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH AN AMINO-2-INDANOL COMPOUND |
3MA2 | D:118-284; D:118-284 | COMPLEX MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE (MT1-MMP) WITH TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) |
1RM8 | A:126-291 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-16/MT3-MMP: CHARACTERIZATION OF MT-MMP SPECIFIC FEATURES |
1SU3 | B:108-261; B:108-261 | X-RAY STRUCTURE OF HUMAN PROMMP-1: NEW INSIGHTS INTO COLLAGENASE ACTION |
2TCL | A:8-161 | STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR |
2JSD | A:116-271 | SOLUTION STRUCTURE OF MMP20 COMPLEXED WITH NNGH |
1KS0 | A:4-59 | THE FIRST FIBRONECTIN TYPE II MODULE FROM HUMAN MATRIX METALLOPROTEINASE 2 |
1QIB | A:91-247 | CRYSTAL STRUCTURE OF GELATINASE A CATALYTIC DOMAIN |
1QIA | D:91-247; D:91-247; D:91-247; D:91-247 | CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN |
1QIC | D:91-247; D:91-247; D:91-247; D:91-247 | CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN |
1SLM | A:91-247 | CRYSTAL STRUCTURE OF FIBROBLAST STROMELYSIN-1: THE C-TRUNCATED HUMAN PROENZYME |
1SLN | A:91-247 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-702,842 |
1UEA | C:91-247; C:91-247 | MMP-3/TIMP-1 COMPLEX |
1UMS | A:91-247 | STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR ENSEMBLE OF 20 STRUCTURES |
1UMT | A:91-247 | STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR AVERAGE OF 20 STRUCTURES MINIMIZED WITH RESTRAINTS |
1USN | A:91-247 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-142372 |
2JNP | A:91-247 | SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) |
2JT5 | A:91-247 | SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-HYDROXY-2-[N-(2-HYDROXYETHYL)BIPHENYL-4-SULFONAMIDE] HYDROXAMIC ACID (MLC88) |
2SRT | A:91-247 | CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 AT PH 5.5 AND 40OC COMPLEXED WITH INHIBITOR |
2USN | A:91-247 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-141803 |
3OHL | A:91-247 | CATALYTIC DOMAIN OF STROMELYSIN-1 IN COMPLEX WITH N-HYDROXY-2-(4-METHOXY-N-(PYRIDINE-3-YLMETHYL)PHENYLSULFONAMIDO)ACETAMIDE |
3OHO | A:91-247 | CATALYTIC DOMAIN OF STROMELYSIN-1 IN COMPLEX WITH N-HYDROXY-2-(4-METHYLPHENYLSULFONAMIDO)ACETAMIDE |
3USN | A:9-165 | STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE INHIBITOR IPNU-107859, NMR, 1 STRUCTURE |
1MMP | B:108-263; B:108-263 | MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR |
1MMQ | A:108-263 | MATRILYSIN COMPLEXED WITH HYDROXAMATE INHIBITOR |
2Y6C | A:108-263 | THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER |
2Y6D | A:108-264 | THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER |
1JH1 | A:87-242 | CRYSTAL STRUCTURE OF MMP-8 COMPLEXED WITH A 6H-1,3,4-THIADIAZINE DERIVED INHIBITOR |
1JJ9 | A:87-242 | CRYSTAL STRUCTURE OF MMP8-BARBITURATE COMPLEX REVEALS MECHANISM FOR COLLAGEN SUBSTRATE RECOGNITION |
1KBC | B:87-242; B:87-242 | PROCARBOXYPEPTIDASE TERNARY COMPLEX |
1MMB | A:87-242 | COMPLEX OF BB94 WITH THE CATALYTIC DOMAIN OF MATRIX METALLOPROTEINASE-8 |
1MNC | A:108-263 | STRUCTURE OF HUMAN NEUTROPHIL COLLAGENASE REVEALS LARGE S1' SPECIFICITY POCKET |
1ZP5 | A:87-242 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A N-HYDROXYUREA INHIBITOR |
1ZS0 | A:87-242 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE INHIBITOR (S-ENANTIOMER) |
2OY2 | F:87-242; F:87-242 | HUMAN MMP-8 IN COMPLEX WITH PEPTIDE IAG |
2OY4 | F:87-242; F:87-242 | UNINHIBITED HUMAN MMP-8 |
1L6J | A:115-444 | CRYSTAL STRUCTURE OF HUMAN MATRIX METALLOPROTEINASE MMP9 (GELATINASE B). |
2OVX | B:115-443; B:115-443 | MMP-9 ACTIVE SITE MUTANT WITH BARBITURATE INHIBITOR |
2OW0 | B:115-443; B:115-443 | MMP-9 ACTIVE SITE MUTANT WITH IODINE-LABELED CARBOXYLATE INHIBITOR |
2OW1 | B:115-443; B:115-443 | MMP-9 ACTIVE SITE MUTANT WITH TRIFLUOROMETHYL HYDROXAMATE INHIBITOR |